Intraoperative Ultrasound-Fluoroscopy Fusion can Enhance Prostate Brachytherapy Quality

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 1, 2007, Pages 302-307

  Orio III, Peter F ^a   Tutar, Ismail B ^b   Narayanan, Sreeram ^a   Arthurs, Sandra ^d   Cho, Paul S ^a   Kim, Yongmin ^b,c   Merrick, Gregory ^e   Wallner, Kent E ^a,d,f  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b University of Washington   (United States)

^c University of Washington   (United States)

^d DEPARTMENT OF VETERANS AFFAIRS   (United States)

^e WHEELING HOSPITAL   (United States)

^f CENTER FOR HEALTH STUDIES   (United States)

Author keywords

Brachytherapy; Dosimetry; Pd 103; Prostate

Indexed keywords

IMAGE FUSION; IMAGE QUALITY; IMAGE RECONSTRUCTION; TUMORS; ULTRASONICS;

BRACHYTHERAPY; FLUOROSCOPIC IMAGES; INTRAOPERATIVE DOSES; INTRAOPERATIVE DOSIMETRY; PROSTATE CANCER;

DOSIMETRY;

PALLADIUM 103;

ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; FLUOROSCOPY; HUMAN; MALE; PEROPERATIVE CARE; PRIORITY JOURNAL; PROSTATE CANCER; STATISTICAL SIGNIFICANCE; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT PLANNING;

ALGORITHMS; BRACHYTHERAPY; FLUOROSCOPY; HUMANS; MALE; PALLADIUM; PROSTATIC NEOPLASMS; RADIOISOTOPES; RADIOTHERAPY DOSAGE; ULTRASONOGRAPHY;

EID: 34547842071     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.04.072     Document Type: Article

References (32)

1. Merrick G., Wallner K., and Butler W. Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland. J Urol 169 (2003) 1643-1652
2. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280 (1998) 969-974
3. Blasko J.C., Grimm P.D., Sylvester J.E., et al. Palladium-103 brachytherapy for prostate carcinoma. Int J Radiat Oncol Biol Phys 46 (2000) 839-850
4. Papagikos M., deGuzman A.F., Rossi P., et al. Dosimetric quantifiers for low-dose-rate prostate brachytherapy: Is V100 superior to D90?. Brachytherapy 4 (2005) 252-258
5. Orio P., Wallner K., Merrick G., et al. Dosimetric parameters as predictive factors for biochemical control in patients with higher risk prostate cancer treated with Pd-103 and supplemental beam radiation. Int J Radiat Oncol Biol Phys 67 (2007) 342-346
6. Herstein A., Wallner K., Merrick G., et al. There is a wide range of predictive dosimetric factors for I-125 and Pd-103 prostate brachytherapy. Am J Clin Oncol (2007) in press
7. Stock R.G., Stone N.N., Cesaaretti J., et al. Biologically effective dose values for prostate brachytherrapy: Effects on PSA failure and posttreatment biopsy results. Int J Radiat Oncol Biol Phys 64 (2006) 527-533
8. Potters L., Huang D., Calugaru E., et al. Importance of implant dosimetry for patients undergoing prostate brachytherapy. Urology 62 (2003) 1073-1077
9. Nag S., Bice W., DeWyngaert K., et al. The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys 46 (2000) 221-230
10. Chen Z., Yue N., Wang X., et al. Dosimetric effects of edema in permanent prostate seed implants: A rigorous solution. Int J Radiat Oncol Biol Phys 47 (2000) 1405-1419
11. Waterman F.M., and Dicker A.P. Impact of postimplant edema on V100 and D90 in prostate brachytherapy: Can implant quality be predicted on day 0?. Int J Radiat Oncol Biol Phys 53 (2002) 610-621
12. Reed D., Wallner K., Narayanan S., et al. Intra-operative fluoroscopic dose assessment in prostate brachytherapy patients. Int J Radiat Oncol Biol Phys 63 (2005) 301-307
13. Gong L., Cho P., Han B., et al. Registration of prostate brachytherapy seeds with prostate anatomy for postimplant dosimetry. Int J Radiat Oncol Biol Phys 54 (2002) 1322-1330
14. Lee E.K., and Zaider M. Intraoperative dynamic dose optimization in permanent prostate implants. Int J Radiat Oncol Biol Phys 56 (2003) 854-861
15. Zelefsky M.J., Yamada Y., Cohen G., et al. Postimplantation dosimetric analysis of permanent transperineal prostate implantation: Improved dose distributions with an intraoperative computer-optimized conformal planning technique. Int J Radiat Oncol Biol Phys 48 (2000) 601-608
16. Su Y., Davis B., Herman M., et al. Fluoroscopy to ultrasound image registration using implanted seeds as fiducials during permanent prostate brachytherapy. Proc SPIE 5367 (2004) 371-378
17. Potters L., Calguaru E., Thornton K., et al. Toward a dynamic real-time intraoperative permanent prostate brachytherapy methodology. Brachytherapy 2 (2003) 172-180
18. Merrick G.S., and Butler W.M. Modified uniform seed loading for prostate brachytherapy: Rationale, design, and evaluation. Tech Urol 6 (2000) 78-84
19. Wallner K., Merrick G., Blasko J., et al. Design. In: Wallner K., Merrick G., Blasko J., et al. (Eds). Prostate brachytherapy made complicated. 3rd ed. (2007), SmartMedicine Press, Seattle 13.11-13.26
20. Mueller A., Wallner K., Corriveau J., et al. A reappraisal of local anesthesia for prostate brachytherapy. Radiother Oncol 67 (2003) 309-312
21. Tutar I., Gong L., and Narayanan S. Seed-based ultrasound and fluoroscopy registration using iterative optimal assignment for intraoperative prostate brachytherapy dosimetry. Proc SPIE Med Imag 6509 (2007) 14-21
22. Narayanan S., Cho P., and Marks R. Fast cross-projection algorithm for reconstruction of seeds in prostate brachytherapy. Med Phys 29 (2002) 1572-1579
23. Narayanan S., Cho P., and Marks R. 3D seed reconstruction from incomplete data set in prostate brachytherapy. Phys Med Biol 49 (2004) 3483-3494
24. Tutar I, Gong L, Narayanan S. Seed-based TRUS-fluoroscopy registration method for intraoperative dosimetry ananlysis of prostate brachytherapy. Med Phys. In press.
25. Han B., Wallner K., Merrick G., et al. The effect of inter-observer differences in post-implant prostate CT image interpretation on dosimetric parameters. Med Phys 30 (2003) 1096-1104
26. Crook J., Milosevic M., Catton P., et al. Interobserver variation in postimplant computed tomography contouring affects quality assessment of prostate brachytherapy. Brachytherapy 1 (2002) 66-73
27. Mueller A., Wallner K., Merrick G., et al. Peri-rectal seeds as a risk factor for prostate brachytherapy-related rectal bleeding. Int J Radiat Oncol Biol Phys 59 (2004) 1047-1052
28. Snyder K.M., Stock R.G., Hong S.M., et al. Defining the risk of developing grade 2 proctitis following 125-I prostate brachytherapy using a rectal dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 50 (2001) 335-341
29. Wallner K.E., Roy J., and Harrison L. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys 32 (1995) 465-471
30. Sloboda R., Pedersen J., and Halperin R. Is there a preferred strength for regularly spaced 125-I seeds in inverse-planned prostate implant?. Int J Radiat Oncol Biol Phys 55 (2003) 234-244
31. Narayana V., Troyer S., Evans V., et al. Randomized trial of high- and low-source strength 125-I prostate seed implants. Int J Radiat Oncol Biol Phys 61 (2005) 44-51
32. Wallner K., Merrick G., Sutlief S., et al. High-dose regions versus likelihood of cure after prostate brachytherapy. Int J Radiat Oncol Biol Phys 62 (2005) 170-174